Review: Practical considerations in ovarian cancer chemotherapy

Review: Practical considerations in ovarian cancer chemotherapy

Epithelial ovarian cancer remains the most lethal gynecologic malignancy despite advances in treatment. The standard management generally involves a combination of surgical tumor debulking and chemotherapy. Over the decades, chemotherapy for ovarian cancer has evolved and currently involves a combin...

Full description

Bibliographic Details
Main Authors:	Mihaela Cristea MD, Ernest Han, Lennie Salmon, Robert J. Morgan
Format:	Article
Language:	English
Published:	SAGE Publishing 2010-05-01
Series:	Therapeutic Advances in Medical Oncology
Online Access:	https://doi.org/10.1177/1758834010361333

Similar Items

Intraperitoneal chemotherapy in ovarian cancer: a review of tolerance and efficacy
by: Chua TC, et al.
Published: (2012-11-01)

Hyperthermic Intraperitoneal Chemotherapy in Ovarian Cancer
by: McKayla J. Riggs, et al.
Published: (2020-01-01)

Chemotherapy of ovarian cancer in elderly patients
by: Tiffany A. Troso-Sandoval, et al.
Published: (2015-12-01)

mutation in ovarian cancer: testing, implications and treatment considerations
by: Robert T. Neff, et al.
Published: (2017-08-01)

Emerging Trends in Neoadjuvant Chemotherapy for Ovarian Cancer
by: Ami Patel, et al.
Published: (2021-02-01)

Biological Insights into Chemotherapy Resistance in Ovarian Cancer
by: Michelle A. Glasgow, et al.
Published: (2019-04-01)

The Controversy of Intraperitoneal Hyperthermic Chemotherapy for Ovarian Cancer
by: Lucian ALECU, et al.
Published: (2020-12-01)

Predictive Value of HE4 in Platinum-Based Chemotherapy for Ovarian Cancer: A Systematic Review
by: Yue Han, et al.
Published: (2021-07-01)

Clinical resistance to platinum chemotherapy in ovarian cancer
by: Newton, C.
Published: (2009)

Ovarian Reserve after Chemotherapy in Breast Cancer: A Systematic Review and Meta-Analysis
by: Alessia Romito, et al.
Published: (2021-07-01)

Heated Intraperitoneal Chemotherapy in the Management of Advanced Ovarian Cancer
by: Andrea Jewell, et al.
Published: (2018-09-01)

Intraperitoneal chemotherapy in the management of ovarian cancer: focus on carboplatin
by: Maurie Markman
Published: (2009-02-01)

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer
by: Della Pepa C, et al.
Published: (2014-06-01)

The impact of cisplat based chemotherapy on advanced ovarian cancer.
by: Prasad G, et al.
Published: (1995-10-01)

Immune infiltration in ovarian cancer and its significance in chemotherapy
by: Lo, Charlotte Sum-Yee
Published: (2015)

Primary chemotherapy patterns for ovarian cancer treatment in Japan
by: Shirai, Takako
Published: (2010)

Ovarian reserve testing in premenopausal recipients of chemotherapy for breast cancer
by: Singh, K. J. D. L.
Published: (2008)

Ovarian Cancer therapy combining the modalities of hyperthermia and chemotherapy
by: Chowdhury, Mohd Raquibul
Published: (2007)

Molecular Characterization of Non-responders to Chemotherapy in Serous Ovarian Cancer
by: Megan E. McDonald, et al.
Published: (2019-03-01)

Considerations regarding pedagogical practice of physical education students at gymnasium
by: Dana Ioana CRISTEA, et al.
Published: (2017-07-01)

Survival and recurrence after intraperitoneal chemotherapy use: Retrospective review of ovarian cancer hospital registry data
by: Shalkar Adambekov, et al.
Published: (2020-10-01)

Effect of delayed palliative chemotherapy on survival of patients with recurrent ovarian cancer.
by: Seung Yeon Pyeon, et al.
Published: (2020-01-01)

Prognostic impact of adjuvant chemotherapy treatment intensity for ovarian cancer.
by: Kristen D Starbuck, et al.
Published: (2018-01-01)

Changes of Intestinal Microbiota in Ovarian Cancer Patients Treated with Surgery and Chemotherapy
by: Tong J, et al.
Published: (2020-09-01)

Chemotherapy resumption in ovarian cancer patient diagnosed with COVID-19
by: Michalis Liontos, et al.
Published: (2020-08-01)

Chemotherapy weakly contributes to predicted neoantigen expression in ovarian cancer
by: Timothy O’Donnell, et al.
Published: (2018-01-01)

HDAC1 Silencing in Ovarian Cancer Enhances the Chemotherapy Response
by: Xinfeng Liu, et al.
Published: (2018-08-01)

Bevacizumab in combination with chemotherapy in platinum-sensitive ovarian cancer [Corrigendum]
by: Della Pepa C, et al.
Published: (2014-08-01)

Enhancing chemotherapy response with Bmi-1 silencing in ovarian cancer.
by: Enfeng Wang, et al.
Published: (2011-03-01)

Neoadjuvant chemotherapy for IIIC stage ovarian cancer - case report
by: Aleksandra Obuchowska, et al.
Published: (2020-09-01)

The evolution of hyperthermic intraperitoneal chemotherapy in the setting of advanced ovarian cancer
by: Quindlen, Kevin John
Published: (2019)

The first experience with intraabdominal chemotherapy in patients with disseminated ovarian cancer
by: A. S. Tyulyandina, et al.
Published: (2014-08-01)

Impact of Chemotherapy Dosing Schedule on Ovarian Cancer Tumor Responsiveness
by: De Souza, Raquel S. M. G.
Published: (2012)

Impact of Chemotherapy Dosing Schedule on Ovarian Cancer Tumor Responsiveness
by: De Souza, Raquel S. M. G.
Published: (2012)

The identification of novel genes involved in chemotherapy resistance in ovarian cancer
by: Gilmore, Paula
Published: (1997)

Biomarkers for prediction of chemotherapy response and survival in ovarian cancer patients
by: Yi-Jou Tai, et al.
Published: (2014)

Evaluation of drug combinations to sensitize ovarian cancer cells to chemotherapy
by: Abo Donia, Mohammed Najim Abed
Published: (2018)

Chemotherapy Associated Ovarian Failure
by: Davide Mauri, et al.
Published: (2020-12-01)

Recurrent Pseudomembranous Colitis in an Ovarian Cancer Patient Undergoing Carboplatin Chemotherapy
by: Valerie A. Allen, et al.
Published: (2016-01-01)

The addition of sodium thiosulphate to hyperthermic intraperitoneal chemotherapy with cisplatin in ovarian cancer
by: Kate Glennon, et al.
Published: (2021-08-01)